Meyka AI API is live for developers.Start building.
Advertisement
Claritev Corporation

Claritev Corporation Fundamental Analysis

CTEVNYSE
HealthcareMedical - Healthcare Information Services
$25.84
$1.73(6.27%)
U.S. Market opens in 54h 15m
Advertisement

Claritev Corporation Fundamental Analysis

Claritev Corporation (CTEV) shows moderate financial fundamentals with a PE ratio of -1.50, profit margin of -29.27%, and ROE of 2.06%. The company generates $1.0B in annual revenue with moderate year-over-year growth of 3.74%.

Key Strengths

PEG Ratio-0.01

Areas of Concern

ROE2.06%
Operating Margin4.29%
Cash Position4.94%
We analyze CTEV's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 215.8/100 based on profitability, valuation, growth, and balance sheet metrics. The A grade reflects excellent fundamentals and strong overall stability.

Fundamental Health Score

A
215.8/100

We analyze CTEV's fundamental strength across five key dimensions:

Efficiency Score

Weak

CTEV struggles to generate sufficient returns from assets.

ROA > 10%
-5.92%

Valuation Score

Excellent

CTEV trades at attractive valuation levels.

PE < 25
-1.50
PEG Ratio < 2
-0.01

Growth Score

Moderate

CTEV shows steady but slowing expansion.

Revenue Growth > 5%
3.74%
EPS Growth > 10%
83.03%

Financial Health Score

Excellent

CTEV maintains a strong and stable balance sheet.

Debt/Equity < 1
-19.11
Current Ratio > 1
1.28

Profitability Score

Weak

CTEV struggles to sustain strong margins.

ROE > 15%
205.84%
Net Margin ≥ 15%
-29.27%
Positive Free Cash Flow
No

Key Financial Metrics

Is CTEV Expensive or Cheap?

P/E Ratio

CTEV trades at -1.50 times earnings. This suggests potential undervaluation.

-1.50

PEG Ratio

When adjusting for growth, CTEV's PEG of -0.01 indicates potential undervaluation.

-0.01

Price to Book

The market values Claritev Corporation at -1.79 times its book value. This may indicate undervaluation.

-1.79

EV/EBITDA

Enterprise value stands at -7.99 times EBITDA. This is generally considered low.

-7.99

How Well Does CTEV Make Money?

Net Profit Margin

For every $100 in sales, Claritev Corporation keeps $-29.27 as profit after all expenses.

-29.27%

Operating Margin

Core operations generate 4.29 in profit for every $100 in revenue, before interest and taxes.

4.29%

ROE

Management delivers $2.06 in profit for every $100 of shareholder equity.

2.06%

ROA

Claritev Corporation generates $-5.92 in profit for every $100 in assets, demonstrating efficient asset deployment.

-5.92%

Following the Money - Real Cash Generation

Operating Cash Flow

Claritev Corporation produces operating cash flow of $100.84M, showing steady but balanced cash generation.

$100.84M

Free Cash Flow

Claritev Corporation generates weak or negative free cash flow of $-39.59M, restricting financial flexibility.

$-39.59M

FCF Per Share

Each share generates $-2.32 in free cash annually.

$-2.32

FCF Yield

CTEV converts -8.74% of its market value into free cash.

-8.74%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-1.50

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.01

vs 25 benchmark

P/B Ratio

Price to book value ratio

-1.79

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.45

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-19.11

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.28

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

2.06

vs 25 benchmark

ROA

Return on assets percentage

-0.06

vs 25 benchmark

ROCE

Return on capital employed

0.009

vs 25 benchmark

How CTEV Stacks Against Its Sector Peers

MetricCTEV ValueSector AveragePerformance
P/E Ratio-1.5029.20 Better (Cheaper)
ROE205.84%729.00% Weak
Net Margin-29.27%-52856.00% (disorted) Weak
Debt/Equity-19.110.49 Strong (Low Leverage)
Current Ratio1.284.43 Neutral
ROA-5.92%-20711.00% (disorted) Weak

CTEV outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Claritev Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-26.27%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

60.89%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

-77.74%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ